Financial results for March 31 , 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Adline Chem Lab Ltd submitted its audited standalone results for Q4 and FY25. The company reported a Q4 standalone profit of Rs 20.94 lakhs, swinging from a Q4 FY24 loss of Rs 8.27 lakhs. However, the full year remained in the red with a PAT loss of Rs 13.22 lakhs, though narrowed from Rs 27.18 lakhs in FY24. Total income for the year stood at Rs 24.89 lakhs, with the entire revenue appearing to come from a one-time modification of financial liabilities. The auditor's review flagged concerns about material modifications to a contract with related party Vivanza Lifescience Pvt Ltd, where prior shareholder approval for the transaction was not obtained. Operating cash flow stayed negative at Rs (22.61) lakhs. The board also approved a new Internal Auditor and Secretarial Auditor, while accepting the resignation of Company Secretary Mrs. Ritu Singh.
Despite a Q4 profit, the company continues to post annual losses and has accumulated losses of Rs 733.95 lakhs against a share capital of Rs 585 lakhs, indicating serious going concern risks for shareholders. The auditor's specific emphasis on an unapproved related party transaction and persistent negative operating cash flow are red flags that could weigh on the stock price.